Rentokil Initial Plc Stock Net Asset
Rentokil Initial PLC fundamentals help investors to digest information that contributes to Rentokil Initial's financial success or failures. It also enables traders to predict the movement of Rentokil Pink Sheet. The fundamental analysis module provides a way to measure Rentokil Initial's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rentokil Initial pink sheet.
Rentokil |
Rentokil Initial PLC Company Net Asset Analysis
Rentokil Initial's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Rentokil Initial Net Asset | 4.32 B |
Most of Rentokil Initial's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rentokil Initial PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Rentokil Initial PLC has a Net Asset of 4.32 B. This is much higher than that of the Industrials sector and significantly higher than that of the Specialty Business Services industry. The net asset for all United States stocks is notably lower than that of the firm.
Rentokil Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rentokil Initial's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rentokil Initial could also be used in its relative valuation, which is a method of valuing Rentokil Initial by comparing valuation metrics of similar companies.Rentokil Initial is currently under evaluation in net asset category among its peers.
Rentokil Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0419 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 11.45 B | |||
| Shares Outstanding | 372.77 M | |||
| Shares Owned By Institutions | 0.84 % | |||
| Price To Earning | 37.07 X | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 2.96 B | |||
| Gross Profit | 2.37 B | |||
| EBITDA | 656.6 M | |||
| Net Income | 263.2 M | |||
| Cash And Equivalents | 2.37 B | |||
| Cash Per Share | 6.38 X | |||
| Total Debt | 1.26 B | |||
| Debt To Equity | 2.64 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 3.87 X | |||
| Cash Flow From Operations | 563.2 M | |||
| Earnings Per Share | 0.80 X | |||
| Price To Earnings To Growth | 1.43 X | |||
| Target Price | 13.46 | |||
| Number Of Employees | 46 K | |||
| Beta | 0.44 | |||
| Market Capitalization | 9.6 B | |||
| Total Asset | 4.32 B | |||
| Retained Earnings | 2.07 B | |||
| Working Capital | (196 M) | |||
| Current Asset | 593 M | |||
| Current Liabilities | 789 M | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.23 % | |||
| Net Asset | 4.32 B | |||
| Last Dividend Paid | 0.067 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Rentokil Pink Sheet
If you are still planning to invest in Rentokil Initial PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rentokil Initial's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |